Concord Asset Management LLC VA Takes Position in Humana Inc. (NYSE:HUM)

Concord Asset Management LLC VA bought a new stake in shares of Humana Inc. (NYSE:HUM) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,050 shares of the insurance provider’s stock, valued at approximately $266,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of HUM. International Assets Investment Management LLC raised its holdings in shares of Humana by 261,025.1% in the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after buying an additional 738,701 shares during the period. FMR LLC increased its stake in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the period. Thrivent Financial for Lutherans boosted its stake in shares of Humana by 55.6% during the third quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock valued at $190,145,000 after purchasing an additional 214,535 shares during the period. Pzena Investment Management LLC grew its holdings in shares of Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after purchasing an additional 187,903 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new position in Humana in the 3rd quarter worth about $50,102,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 1.2 %

Humana stock opened at $293.40 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a market cap of $35.33 billion, a PE ratio of 25.99, a PEG ratio of 2.22 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business’s 50-day simple moving average is $275.36 and its two-hundred day simple moving average is $302.40.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities analysts anticipate that Humana Inc. will post 16.11 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Morgan Stanley upped their target price on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Barclays raised their price objective on Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 22nd. Jefferies Financial Group cut Humana from a “buy” rating to a “hold” rating and lowered their target price for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Royal Bank of Canada cut their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Finally, TD Cowen upped their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $297.68.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by corporate insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.